344 related articles for article (PubMed ID: 2926086)
1. Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency.
Bork K; Witzke G
J Allergy Clin Immunol; 1989 Mar; 83(3):677-82. PubMed ID: 2926086
[TBL] [Abstract][Full Text] [Related]
2. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L
J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic approach of hereditary angioedema].
Chagas Kde N; Arruk VG; Andrade ME; Vasconcelos Dde M; Kirschfink M; Duarte AJ; Grumach AS
Rev Assoc Med Bras (1992); 2004; 50(3):314-9. PubMed ID: 15499486
[TBL] [Abstract][Full Text] [Related]
4. [Hereditary angioedema in the German-speaking region].
Göring HD; Bork K; Späth PJ; Bauer R; Ziemer A; Hintner H; Wüthrich B
Hautarzt; 1998 Feb; 49(2):114-22. PubMed ID: 9551333
[TBL] [Abstract][Full Text] [Related]
5. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema.
Bork K; Barnstedt SE
Arch Intern Med; 2001 Mar; 161(5):714-8. PubMed ID: 11231704
[TBL] [Abstract][Full Text] [Related]
6. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients.
Agostoni A; Cicardi M
Medicine (Baltimore); 1992 Jul; 71(4):206-15. PubMed ID: 1518394
[TBL] [Abstract][Full Text] [Related]
7. Clinical problems in the C1-inhibitor deficient patient.
Agostoni A; Cicardi M; Cugno M; Storti E
Behring Inst Mitt; 1993 Dec; (93):306-12. PubMed ID: 8172581
[TBL] [Abstract][Full Text] [Related]
8. [The use of a C1-inhibior concentrate for short-term preoperative prophylaxis in two patients with hereditary angioedema].
Mohr M; Pollok-Kopp B; Götze O; Burchardi H
Anaesthesist; 1996 Jul; 45(7):626-30. PubMed ID: 8765863
[TBL] [Abstract][Full Text] [Related]
9. C1-inhibitor deficiency and angioedema.
Carugati A; Pappalardo E; Zingale LC; Cicardi M
Mol Immunol; 2001 Aug; 38(2-3):161-73. PubMed ID: 11532278
[TBL] [Abstract][Full Text] [Related]
10. The use of plasma-derived C1 inhibitor in the treatment of hereditary angioedema.
Cicardi M; Zingale LC; Zanichelli A; Deliliers DL; Caccia S
Expert Opin Pharmacother; 2007 Dec; 8(18):3173-81. PubMed ID: 18035961
[TBL] [Abstract][Full Text] [Related]
11. [Hereditary angioedema. Control and treatment in 7 cases].
Marqués L; Dordal T; Baltasar M; Guspi R; Nogueiras C; Cadahia A
Med Clin (Barc); 1992 Mar; 98(10):378-80. PubMed ID: 1564970
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.
Cicardi M; Zingale LC; Pappalardo E; Folcioni A; Agostoni A
Medicine (Baltimore); 2003 Jul; 82(4):274-81. PubMed ID: 12861105
[TBL] [Abstract][Full Text] [Related]
13. [Profhylaxis and treatment of hereditary and acquired angioedema at HUB; use of the C1-esterase inhibitor].
Pastó Cardona L; Bordas Orpinell J; Mercadal Orfila G; Pérez de la Vara A; Jódar Massanés R
Farm Hosp; 2003; 27(6):346-52. PubMed ID: 14974880
[TBL] [Abstract][Full Text] [Related]
14. Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations.
Wagenaar-Bos IG; Drouet C; Aygören-Pursun E; Bork K; Bucher C; Bygum A; Farkas H; Fust G; Gregorek H; Hack CE; Hickey A; Joller-Jemelka HI; Kapusta M; Kreuz W; Longhurst H; Lopez-Trascasa M; Madalinski K; Naskalski J; Nieuwenhuys E; Ponard D; Truedsson L; Varga L; Nielsen EW; Wagner E; Zingale L; Cicardi M; van Ham SM
J Immunol Methods; 2008 Sep; 338(1-2):14-20. PubMed ID: 18655790
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune C1 inhibitor deficiency: report of eight patients.
Cicardi M; Bisiani G; Cugno M; Späth P; Agostoni A
Am J Med; 1993 Aug; 95(2):169-75. PubMed ID: 8356982
[TBL] [Abstract][Full Text] [Related]
16. Nanofiltered human C1 inhibitor concentrate (Cinryze®): in hereditary angioedema.
Lyseng-Williamson KA
BioDrugs; 2011 Oct; 25(5):317-27. PubMed ID: 21942916
[TBL] [Abstract][Full Text] [Related]
17. C1-INH defect as an example of deficiency disease.
Madaliński K; Sabbouh K; Chorazykiewicz M; Gregorek H
Immunol Invest; 1991 Apr; 20(2):133-41. PubMed ID: 1864632
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol.
Pappalardo E; Zingale LC; Cicardi M
Immunol Lett; 2003 May; 86(3):271-6. PubMed ID: 12706530
[TBL] [Abstract][Full Text] [Related]
19. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency.
Caballero T; Farkas H; Bouillet L; Bowen T; Gompel A; Fagerberg C; Bjökander J; Bork K; Bygum A; Cicardi M; de Carolis C; Frank M; Gooi JH; Longhurst H; Martínez-Saguer I; Nielsen EW; Obtulowitz K; Perricone R; Prior N;
J Allergy Clin Immunol; 2012 Feb; 129(2):308-20. PubMed ID: 22197274
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
